245 related articles for article (PubMed ID: 23730209)
1. Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer.
Yakubov B; Chelladurai B; Schmitt J; Emerson R; Turchi JJ; Matei D
Neoplasia; 2013 Jun; 15(6):609-19. PubMed ID: 23730209
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase.
Shao M; Cao L; Shen C; Satpathy M; Chelladurai B; Bigsby RM; Nakshatri H; Matei D
Cancer Res; 2009 Dec; 69(24):9192-201. PubMed ID: 19951993
[TBL] [Abstract][Full Text] [Related]
3. Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer.
Cao L; Shao M; Schilder J; Guise T; Mohammad KS; Matei D
Oncogene; 2012 May; 31(20):2521-34. PubMed ID: 21963846
[TBL] [Abstract][Full Text] [Related]
4. Tissue transglutaminase constitutively activates HIF-1α promoter and nuclear factor-κB via a non-canonical pathway.
Kumar S; Mehta K
PLoS One; 2012; 7(11):e49321. PubMed ID: 23185316
[TBL] [Abstract][Full Text] [Related]
5. Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling.
Cao L; Petrusca DN; Satpathy M; Nakshatri H; Petrache I; Matei D
Carcinogenesis; 2008 Oct; 29(10):1893-900. PubMed ID: 18667446
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of transglutaminase 2 (TG2) at serine-216 has a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTEN.
Wang Y; Ande SR; Mishra S
BMC Cancer; 2012 Jul; 12():277. PubMed ID: 22759359
[TBL] [Abstract][Full Text] [Related]
7. Small Molecules Target the Interaction between Tissue Transglutaminase and Fibronectin.
Sima LE; Yakubov B; Zhang S; Condello S; Grigorescu AA; Nwani NG; Chen L; Schiltz GE; Arvanitis C; Zhang ZY; Matei D
Mol Cancer Ther; 2019 Jun; 18(6):1057-1068. PubMed ID: 31015308
[TBL] [Abstract][Full Text] [Related]
8. Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism.
Condello S; Cao L; Matei D
FASEB J; 2013 Aug; 27(8):3100-12. PubMed ID: 23640056
[TBL] [Abstract][Full Text] [Related]
9. The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
Kotsakis P; Wang Z; Collighan RJ; Griffin M
Amino Acids; 2011 Oct; 41(4):909-21. PubMed ID: 21046178
[TBL] [Abstract][Full Text] [Related]
10. Tissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity.
Satpathy M; Shao M; Emerson R; Donner DB; Matei D
J Biol Chem; 2009 Jun; 284(23):15390-9. PubMed ID: 19324884
[TBL] [Abstract][Full Text] [Related]
11. Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase.
Satpathy M; Cao L; Pincheira R; Emerson R; Bigsby R; Nakshatri H; Matei D
Cancer Res; 2007 Aug; 67(15):7194-202. PubMed ID: 17671187
[TBL] [Abstract][Full Text] [Related]
12. Activation of noncanonical NF-kappaB signaling by the oncoprotein Tio.
de Jong SJ; Albrecht JC; Schmidt M; Müller-Fleckenstein I; Biesinger B
J Biol Chem; 2010 May; 285(22):16495-503. PubMed ID: 20353939
[TBL] [Abstract][Full Text] [Related]
13. The homeoprotein DLX4 stimulates NF-κB activation and CD44-mediated tumor-mesothelial cell interactions in ovarian cancer.
Haria D; Trinh BQ; Ko SY; Barengo N; Liu J; Naora H
Am J Pathol; 2015 Aug; 185(8):2298-308. PubMed ID: 26067154
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
Cherry EM; Lee DW; Jung JU; Sitcheran R
Mol Cancer; 2015 Jan; 14(1):9. PubMed ID: 25622756
[TBL] [Abstract][Full Text] [Related]
15. Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor Niche.
Condello S; Sima L; Ivan C; Cardenas H; Schiltz G; Mishra RK; Matei D
Cancer Res; 2018 Jun; 78(11):2990-3001. PubMed ID: 29510995
[TBL] [Abstract][Full Text] [Related]
16. Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells.
Lin CY; Tsai PH; Kandaswami CC; Chang GD; Cheng CH; Huang CJ; Lee PP; Hwang JJ; Lee MT
Mol Cancer; 2011 Jul; 10():87. PubMed ID: 21777419
[TBL] [Abstract][Full Text] [Related]
17. Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells.
Kumar A; Xu J; Sung B; Kumar S; Yu D; Aggarwal BB; Mehta K
Breast Cancer Res; 2012 Jan; 14(1):R4. PubMed ID: 22225906
[TBL] [Abstract][Full Text] [Related]
18. The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice.
Sawada I; Hashimoto K; Sawada K; Kinose Y; Nakamura K; Toda A; Nakatsuka E; Yoshimura A; Mabuchi S; Fujikawa T; Itai A; Kimura T
Int J Gynecol Cancer; 2016 May; 26(4):610-8. PubMed ID: 26905334
[TBL] [Abstract][Full Text] [Related]
19. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.
Jang GY; Jeon JH; Cho SY; Shin DM; Kim CW; Jeong EM; Bae HC; Kim TW; Lee SH; Choi Y; Lee DS; Park SC; Kim IG
Oncogene; 2010 Jan; 29(3):356-67. PubMed ID: 19838207
[TBL] [Abstract][Full Text] [Related]
20. Tissue transglutaminase expression promotes castration-resistant phenotype and transcriptional repression of androgen receptor.
Han AL; Kumar S; Fok JY; Tyagi AK; Mehta K
Eur J Cancer; 2014 Jun; 50(9):1685-96. PubMed ID: 24656569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
